Genetic Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GENE and other ETFs, options, and stocks.About GENE
Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments.
CEOSimon Morriss
CEOSimon Morriss
Employees60
Employees60
HeadquartersFitzroy, Victoria (VIC)
HeadquartersFitzroy, Victoria (VIC)
Founded1987
Founded1987
Employees60
Employees60
GENE Key Statistics
Market cap10.08M
Market cap10.08M
Price-Earnings ratio-0.08
Price-Earnings ratio-0.08
Dividend yield—
Dividend yield—
Average volume36.85K
Average volume36.85K
High today$2.46
High today$2.46
Low today$2.13
Low today$2.13
Open price$2.42
Open price$2.42
Volume28.23K
Volume28.23K
52 Week high$5.90
52 Week high$5.90
52 Week low$1.80
52 Week low$1.80
GENE News
TipRanks 1d
BNYMC Increases Stake in Genetic TechnologiesGenetic Technologies Limited (AU:GTG) has released an update. Genetic Technologies Limited has experienced a notable increase in the voting power of its substa...
TipRanks 2d
Genetic Technologies’ News Release Lacks DetailsGenetic Technologies (GENE) has released an update. Genetic Technologies’ latest news release contains no textual information, consisting only of placeholder H...
TipRanks 2d
Genetic Technologies Secures $2M InvestmentGenetic Technologies (GENE) has released an update. Genetic Technologies has successfully secured a $2 million investment through a private placement of shares...
More GENE News
Seeking Alpha 7d
Genetic Technologies stock tumbles on direct offering pricingGenetic Technologies (NASDAQ:GENE) stock tumbled 26% in afternoon trading Thursday after the genomics-based test developer announced a $2M registered direct off...
